BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Diagnosis
15 results:

  • 1. Tumor-suppressive role of microfibrillar associated protein 4 and its clinical significance as prognostic factor and diagnostic biomarker in hepatocellular carcinoma.
    Li J; Wang J; Liu Z; Guo H; Wei X; Wei Q; Zheng S; Xu X
    J Cancer Res Ther; 2022 Dec; 18(7):1919-1925. PubMed ID: 36647950
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Construction of a combined random forest and artificial neural network diagnosis model to screening potential biomarker for hepatoblastoma.
    Liu S; Zheng Q; Zhang R; Li T; Zhan J
    Pediatr Surg Int; 2022 Dec; 38(12):2023-2034. PubMed ID: 36271952
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer.
    Bray AW; Duan R; Malalur P; Drusbosky LM; Gourdin TS; Hill EG; Lilly MB
    Prostate; 2022 Sep; 82(13):1264-1272. PubMed ID: 35766303
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma.
    Wang Y; Zhang Y; Mi J; Jiang C; Wang Q; Li X; Zhao M; Geng Z; Song X; Li J; Zuo L; Ge S; Zhang Z; Wen H; Wang Z; Su F
    Oncogene; 2022 Jul; 41(29):3680-3693. PubMed ID: 35725908
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Descriptive analysis of incidental and operable gallbladder carcinoma cases: a UK centre experience.
    Karunaratne S; Gamage A; Bagwan IN
    Pathologica; 2022 Apr; 114(2):138-145. PubMed ID: 35481564
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
    Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH
    J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. eIF6 promotes the malignant progression of human hepatocellular carcinoma via the mTOR signaling pathway.
    Sun L; Liu S; Wang X; Zheng X; Chen Y; Shen H
    J Transl Med; 2021 May; 19(1):216. PubMed ID: 34016142
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis.
    Mao R; Qiu Y; He JS; Tan JY; Li XH; Liang J; Shen J; Zhu LR; Chen Y; Iacucci M; Ng SC; Ghosh S; Chen MH
    Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):667-678. PubMed ID: 32405603
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia.
    Mateos MK; Trahair TN; Mayoh C; Barbaro PM; Sutton R; Revesz T; Barbaric D; Giles JE; Alvaro F; Mechinaud F; Catchpoole D; Kotecha RS; Dalla-Pozza L; Quinn MCJ; MacGregor S; Chenevix-Trench G; Marshall GM
    Thromb Res; 2019 Jun; 178():132-138. PubMed ID: 31030032
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.
    Fischer MA; Marquez HP; Gordic S; Leidner B; Klotz E; Aspelin P; Alkadhi H; Brismar TB
    Eur Radiol; 2017 Mar; 27(3):1074-1080. PubMed ID: 27368924
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prospective trial with optical molecular imaging for percutaneous interventions in focal hepatic lesions.
    Sheth RA; Arellano RS; Uppot RN; Samir AE; Goyal L; Zhu AX; Gervais DA; Mahmood U
    Radiology; 2015 Mar; 274(3):917-26. PubMed ID: 25302707
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. diagnosis system for hepatocellular carcinoma based on fractal dimension of morphometric elements integrated in an artificial neural network.
    Gheonea DI; Streba CT; Vere CC; Şerbănescu M; Pirici D; Comănescu M; Streba LA; Ciurea ME; Mogoantă S; Rogoveanu I
    Biomed Res Int; 2014; 2014():239706. PubMed ID: 25025042
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Induction of apoptosis in cholangiocarcinoma by an andrographolide analogue is mediated through topoisomerase II alpha inhibition.
    Nateewattana J; Dutta S; Reabroi S; Saeeng R; Kasemsook S; Chairoungdua A; Weerachayaphorn J; Wongkham S; Piyachaturawat P
    Eur J Pharmacol; 2014 Jan; 723():148-55. PubMed ID: 24360936
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.
    Che Y; Ye F; Xu R; Qing H; Wang X; Yin F; Cui M; Burstein D; Jiang B; Zhang DY
    Am J Pathol; 2012 May; 180(5):1798-807. PubMed ID: 22429965
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Role of computerized tomography in the evaluation of extraductal extension of hilar cholangiocarcinoma].
    Frola C; Loria F; De Renzis C; Frosina P; Loria G; Panetta M; Cantoni S
    Radiol Med; 1994; 88(1-2):63-7. PubMed ID: 8066257
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.